None
Conditions
Interventions
Intake 5 tablets of the test food for 12 weeks
Intake 5 tablets of the placebo food for 12 weeks
Sponsors
KSO Corporation
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Males and females aged of 20-64 years at the date of informed consent 2) Subjects whose BMI 24 kg/m2 or more and less than 30 kg/m2 3) Subjects who have received a sufficient explanation of the purpose and content of the study, have the consent ability and good understandings, and have agreed voluntarily in writing to participate in the study
Exclusion criteria
Exclusion criteria: 1)Subjects who use pharmaceuticals affecting the study 2)Subjects who have a history of severe kidney disease, heart disease, respiratory disease, endocrine disease, diabetes, etc., and undergoing treatment for them (excluding transient treatment such as colds) 3)Subjects who cannot stop taking supplements and health foods (including foods for specified health use and foods with functional claims) that may affect something for the test in the study period 4)Subjects who declare some allergies to the components of the test food 5)Subjects who have a history of drug/alcohol dependence or a current medical history 6)Subjects who have metal by surgery and others in measurement areas for CT scan 7)Subjects with implantable medical devices such as cardiac pacemakers and implantable cardioverter-defibrillators 8)Claustrophobic 9)Subjects who are currently pregnant or lactating, or who plan to become pregnant in the study period 10)Subjects who are currently participating in other clinical studies that take or apply other foods, pharmaceuticals, cosmetics, or chemicals, who have participated in other clinical studies within the past month from the date of consent, or who plan to participate in others 11)Subjects judged as unsuitable for this study by the principal investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Abdominal visceral fat area | — |
Secondary
| Measure | Time frame |
|---|---|
| Body weight, BMI, body fat percentage, abdominal total fat area, abdominal subcutaneous fat area, body composition (In Body), circumference, questionnaire survey | — |
Countries
Japan
Contacts
Public ContactEiji Yoshikawa
KSO Corporation Sales department
Outcome results
None listed